A systematic liquid biopsy program identifies novel and heterogeneous mechanisms of acquired resistance in gastrointestinal (GI) cancer patients. (December 2016) - Parikh, A.; Kwak, E.; Goyal, L.; Blaszkowsky, L.; Hazar-Rethinam, M.; Siravegna, G.; Russo, M.; Van Seventer, E.; Nadres, B.; Shahzade, H.; Clark, J.; Allen, J.; et al.